A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia

OBJECTIVES. Biliary atresia (BA) is a progressive neonatal fibroinflammatory cholangiopathy. We hypothesized that intravenous immunoglobulin (IVIg) would be safe, feasible, acceptable and efficacious for the treatment of BA. The primary objective of this study was to establish the feasibility, accep...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	J Pediatr Gastroenterol Nutr
Main Authors:	Mack, Cara L., Spino, Cathie, Alonso, Estella M., Bezerra, Jorge A., Moore, Jeffrey, Goodhue, Catherine, Ng, Vicky L., Karpen, Saul J., Venkat, Veena, Loomes, Kathleen M., Wang, Kasper, Sherker, Averell H., Magee, John C., Sokol, Ronald J.
Format:	Artigo
Sprog:	Inglês
Udgivet:	2019
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6428610/ https://ncbi.nlm.nih.gov/pubmed/30664564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0000000000002256
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

A Phase I/IIa Trial of Intravenous Immunoglobulin Following Portoenterostomy in Biliary Atresia

Lignende værker